GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nano Mrna Co Ltd (TSE:4571) » Definitions » Capex-to-Revenue

Nano Mrna Co (TSE:4571) Capex-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Nano Mrna Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Nano Mrna Co's Capital Expenditure for the three months ended in Dec. 2023 was 円0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was 円13.20 Mil.

Hence, Nano Mrna Co's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.00.


Nano Mrna Co Capex-to-Revenue Historical Data

The historical data trend for Nano Mrna Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nano Mrna Co Capex-to-Revenue Chart

Nano Mrna Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.02 - -

Nano Mrna Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nano Mrna Co's Capex-to-Revenue

For the Biotechnology subindustry, Nano Mrna Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nano Mrna Co's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nano Mrna Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nano Mrna Co's Capex-to-Revenue falls into.



Nano Mrna Co Capex-to-Revenue Calculation

Nano Mrna Co's Capex-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 135.508
=0.00

Nano Mrna Co's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 13.2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nano Mrna Co  (TSE:4571) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Nano Mrna Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nano Mrna Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nano Mrna Co (TSE:4571) Business Description

Traded in Other Exchanges
Address
5-4-19 Kashiwanoha, Chiba, JPN, 277-0882
Nano Mrna Co Ltd formerly NanoCarrier Co Ltd is engaged in the research and development of pharmaceuticals using micellar nanoparticles technology.

Nano Mrna Co (TSE:4571) Headlines

No Headlines